Deakin UniversityBrowse

File(s) not publicly available

Combining MEK and HDAC inhibitors as a therapeutic strategy to promote differentiation of colorectal cancer.

conference contribution
posted on 2017-04-01, 00:00 authored by Laura Jenkins, Ian Luk, Janson Tse, Jennifer Mooi, Amardeep DhillonAmardeep Dhillon, John Mariadason
Combining MEK and HDAC inhibitors as a therapeutic strategy to promote differentiation of colorectal cancer.

History

Event

AACR 2017

Volume

77

Series

Cancer Research

Pagination

3089 - 3089

Publisher

American Association for Cancer Research

Location

Washington, USA

Start date

2017-04-01

End date

2017-04-05

Publication classification

E3 Extract of paper

Title of proceedings

AACR 2017 proceedings

Usage metrics

Research PublicationsResearch Publications

Categories

Keywords

Untagged

Licence

All Rights Reserved

Exports